Last10K.com

Synergy Pharmaceuticals, Inc. (SGYP) SEC Filing 8-K Material Event for the period ending Thursday, October 25, 2018

Synergy Pharmaceuticals, Inc.

CIK: 1347613 Ticker: SGYP

View differences made from one to another to evaluate Synergy Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Synergy Pharmaceuticals, Inc..

Continue

Assess how Synergy Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Synergy Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Synergy Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Ticker: SGYP
CIK: 1347613
Form Type: 8-K Corporate News
Accession Number: 0001104659-18-063974
Submitted to the SEC: Thu Oct 25 2018 5:18:32 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Thursday, October 25, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/sgyp/0001104659-18-063974.htm